- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Eli Lilly shoots for health in new Caitlin Clark ad campaign | ||
| Fr | Targeted Protein Degradation and Novel Modalities: Getting on the Frontline | ||
| Fr | Trump plans to fire FDA chief Marty Makary: report | ||
| Fr | Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill | ||
| Fr | Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma | ||
| Fr | Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory' | ||
| Fr | Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild | ||
| Fr | AbbVie's Skyrizi beats out J&J's Tremfya in in April drug ad spending leaderboard | ||
| Fr | Johnson & Johnson launches 'Generation Fine' depression project | ||
| Fr | Revisiting Pharma's tariff reality | ||
| Fr | GSK tees up a Modern Family for meningitis messaging | ||
| Fr | Pre-launch efforts linked to lasting drug awareness edge: report | ||
| 07.05. | Angelini finds Catalyst for its US growth ambitions with $4.1B buyout | ||
| 07.05. | FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next? | ||
| 07.05. | Insulet CEO details 'Scrubs' device promotion win as it boosts awareness, education drive | ||
| 07.05. | Alnylam rebuked by FDA over efficacy claims on Amvuttra website | ||
| 06.05. | Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report | ||
| 06.05. | FDA rolls out 1-day assessment pilot in bid to refocus inspection resources | ||
| 06.05. | Bayer diagnoses how to build trust in cell and gene therapies | ||
| 06.05. | Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter | ||
| 06.05. | FDA blocks publication of COVID, shingles vaccine safety studies: NYT | ||
| 06.05. | Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma | ||
| 06.05. | Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions | ||
| 06.05. | Lilly to invest $4.5B more into massive Indiana manufacturing complex | ||
| 05.05. | After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.